SBC POD Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
SBC POD
Cefpodoxime Proxetil 50mg
SBC POD (Cefpodoxime Proxetil 50mg) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
The active pharmacological principles in SBC POD deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.
As directed by the registered medical practitioner. Strictly adhere to full course duration.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store in a cool and dry place. Use within 1 month after opening container.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
SBC POD features Cefpodoxime Proxetil 50mg prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Customer & Clinical Reviews
Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.
Based on 1 verified review
Dispensed extensively through our c for SBC POD
SBC POD has been dispensed extensively through our community pharmacy partners, offering dependable therapeutic action that doctors across our territory rely upon daily. The Alu-Alu packing standard ensures complete barrier resistance against light and moisture degradation. Prescription repeat rates have grown month-over-month, confirming strong physician trust.
Questions Regarding SBC POD
What is the therapeutic indication and composition of SBC POD?
SBC POD contains Cefpodoxime Proxetil 50mg indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.
What packaging presentations are available for SBC POD?
SBC POD is supplied in tamper-evident 5ml / 10ml Precision Dropper Bottle with Tamper Ring, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for SBC POD?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SBC POD along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
SBC POD is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.
Related Formulations in Drops
View all Drops →
OTINUS-S NASAL DROPS
Sodium Chloride 0.65% w/v + Benzalkonium Chloride Solution 0.02% v/v